Ozempic Study Shakes Up Market for Kidney and Insulin Treatments

American depositary receipts (ADRs) of Novo Nordisk (NOVO) jumped over 6% in early trading on Wednesday, while shares of kidney dialysis machine and insulin pump makers tumbled, after the drug maker halted a test of its Ozempic diabetes medicine because of its early success in treating kidney…#novonordisk #novo #dmc #ozempic #ckd #novonordisks #dva #baxterinternational #bax #dexcom
Source: Reuters: Health - Category: Consumer Health News Source Type: news